Answers are grounded in this paper and cite their sources.
The rise of antibiotic resistance necessitates the development of advanced antibacterial agents. Here, a ZnO-Co3O4 nanocomposite with varying concentrations is synthesized via the sol-gel method. The structural and morphological features of the as-synthesized nanocomposite are characterized using X-ray diffraction, scanning electron microscopy, and Fourier-transform infrared spectroscopy techniques. The composite design enhances antibacterial performance compared to single oxides. The results revealed that ZnO-Co3O4 nanocomposites exhibit concentration-dependent morphology and antibacterial activity. Notably, ZnO-Co3O4 nanocomposites demonstrated superior antibacterial activity compared to pure ZnO. The addition of cobalt oxide decreased the size of the nanoparticles, thereby enhancing their antibacterial activity, particularly against Gram-positive bacteria, compared to Gram-negative bacteria. This enhanced activity is attributed to the increased production of reactive oxygen species and the improved penetration capability of the nanocomposite.
No takes yet. Share an insight, caveat, or question.
Zahid et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: